Tech Company Financing Transactions
Confluent Surgical Funding Round
Arch Venture Partners, Ascension Ventures and Cross Atlantic Capital Partners invested in a $23 million Series D venture round for Confluent Surgical. The round was announced on 3/30/2005.
Transaction Overview
Company Name
Announced On
3/30/2005
Transaction Type
Venture Equity
Amount
$23,000,000
Round
Series D
Investors
Proceeds Purpose
This strong financial commitment will help Confluent launch the DuraSeal" Dural Sealant system worldwide and amplify the commercial success DuraSeal has been enjoying in select countries outside of the U.S. where it is currently marketed.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
101A First Ave
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Not Recorded
Overview
Confluent Surgical, Inc. is a privately held company developing products based on its proprietary technology of in-situ polymerized hydrogels and associated delivery systems for the field of biosurgery. Confluent is developing products to address the need for surgical sealing and post-surgical adhesion prevention applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amar Sawhney
Browse more venture capital transactions:
Prev: 3/30/2005: Akustica venture capital transaction
Next: 3/30/2005: Ventaira Pharmaceuticals venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs